Article
The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V.
Molecular oncology - 1 May 2014
Noël Laura A, Arts Florence A, Montano-Almendras Carmen P, Cox Luk, Gielen Olga, Toffalini Federica, Marbehant Catherine Y, Cools Jan, Demoulin Jean-Baptiste
Abstract excerpt
Activated forms of the platelet derived growth factor receptor alpha (PDGFRα) have been described in various tumors, including FIP1L1-PDGFRα in patients with myeloproliferative diseases associated with hypereosinophilia and the PDGFRα(D842V) mutant in gastrointestinal stromal tumors and inflammatory fibroid polyps. To gain a better insight into the signal transduction mechanisms of PDGFRα oncogenes, we mutated...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
